- PLN41.18m
- PLN51.92m
- PLN96.31m
Brief: PZ Cormay Decides To Start Review Of Strategic Options For Equisse 400i Project
Brief: PZ Cormay Estimates Q4 Sales Revenue At 21.8 Mln Zlotys, Down 11.2% Y/Y
Brief: PZ Cormay Q3 Net Result Turns To Profit Of 0.5 Mln Zlotys
Brief: PZ Cormay Appoints Marcin Sieczek As CEO
Brief: PZ Cormay Prelim Q3 Sales Revenue Up At 21.9 Mln Zlotys
Brief: PZ Cormay Q2 Net Result Turns To Loss Of 3.5 Mln Zlotys
Brief: PZ Cormay Prelim Q2 Sales Revenue Up At 21.5 Mln Zlotys
Brief: PZ Cormay Q1 Net Result Turns To Loss Of 2.3 Mln Zlotys
Brief: PZ Cormay Submits Equisse To Office For Registration Of Medicinal Products
Brief: PZ Cormay Appoints Flavio Finotello As Acting CEO
Brief: PZ Cormay Asseses Risk With Regards To Current Situation In Ukraine
Brief: PZ Cormay Says Janusz Plocica Resigns As CEO As Of March 18
Brief: PZ Cormay Prelim Q4 Sales Revenue Up At 24.6 Mln Zlotys
Brief: PZ Cormay Q3 Net Loss Widens To 2.6 Mln Zlotys
Brief: PZ Cormay Q2 Net Profit Up At 1.8 Mln Zlotys
Brief: PZ Cormay Says Company's Projects Qualifies For Subsidy Of 1.6 Mln Zlotys
Brief: PZ Cormay Says Chairman Of Supervisory Board Konrad Lapinski Resigns
Brief: PZ Cormay Q1 Net Result Turns To Profit Of 0.9 Mln Zlotys
Brief: PZ Cormay Decides To Stop Development Work On Hermes And Bluebox Analysers